{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:14:15Z","timestamp":1761621255582},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.atherosclerosis.2016.03.018","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T07:00:17Z","timestamp":1458284417000},"page":"210-215","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cholesterol metabolism in cardiac sarcoidosis"],"prefix":"10.1016","volume":"248","author":[{"given":"Piia","family":"Simonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Gylling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Kupari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-015-8481-z","article-title":"Etiologies of sarcoidosis","volume":"49","author":"Chen","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11926-012-0269-z","article-title":"Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies","volume":"14","author":"Amezaga Urruela","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205645","article-title":"What's wrong with this artery? A medical disease discovered by a surgeon","author":"Singh","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib4","first-page":"237","article-title":"Cardiac sarcoidosis and coronary artery disease: a two-hit mechanism to left ventricular dysfunction (Or is it?)","volume":"30","author":"Hansen","year":"2013","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib5","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.ijcard.2013.12.259","article-title":"Necessity for rule out coronary artery disease with the positive findings of 18F-FDG-PET in case of systemic sarcoidosis","volume":"172","author":"Egashira","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0002-9343(89)90332-X","article-title":"High-density lipoprotein cholesterol is reduced in patients with sarcoidosis","volume":"86","author":"Kindman","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(97)00198-6","article-title":"Low levels of high density lipoprotein cholesterol in patients with active sarcoidosis","volume":"136","author":"Salazar","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.clinbiochem.2012.03.009","article-title":"Dyslipidemia and oxidative stress in sarcoidosis patients","volume":"45","author":"Ivani\u0161evi\u0107","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00046-3","article-title":"Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia","volume":"320","author":"Salazar","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.316.7138.1127","article-title":"Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S investigators","volume":"316","author":"Miettinen","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0024-3205(69)90007-1","article-title":"Serum squalene and methyl sterols as indicators of cholesterol synthesis in\u00a0vivo","volume":"8","author":"Miettinen","year":"1969","journal-title":"Life Sci."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-2275(20)38603-X","article-title":"Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver","volume":"28","author":"Bj\u00f6rkhem","year":"1987","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0022-2275(20)38456-X","article-title":"Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans","volume":"29","author":"Kempen","year":"1988","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.aje.a115479","article-title":"Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population","volume":"131","author":"Miettinen","year":"1990","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-2275(20)39911-9","article-title":"Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol","volume":"36","author":"Duane","year":"1995","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.atherosclerosis.2007.08.003","article-title":"The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes","volume":"197","author":"Simonen","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0026-0495(89)90252-7","article-title":"Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men","volume":"38","author":"Miettinen","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib18","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","article-title":"Inhibition of intestinal cholesterol absorption by ezetimibe in humans","volume":"106","author":"Sudhop","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCULATIONAHA.110.006692","article-title":"Combined effects of ezetimibe and phytosterols on cholesterol metabolism. A randomized, controlled feeding study in humans","volume":"124","author":"Lin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib20","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1073\/pnas.0508483103","article-title":"Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels","volume":"103","author":"Cohen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2275(20)38566-7","article-title":"Cholesterol metabolism during ketoconazole treatment in man","volume":"29","author":"Miettinen","year":"1988","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1194\/jlr.E036806","article-title":"Plasma noncholesterol sterols as indicators of cholesterol absorption","volume":"54","author":"Grundy","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2013.11.043","article-title":"plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease","volume":"232","author":"Gylling","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.03.018_bib26","doi-asserted-by":"crossref","first-page":"e0116912","DOI":"10.1371\/journal.pone.0116912","article-title":"Plasma biomarker of dietary phytosterol intake","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9150(00)00368-3","article-title":"Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis","volume":"152","author":"Salazar","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib28","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.C061366","article-title":"SAA: a link between cholesterol efflux capacity and inflammation?","volume":"56","author":"Thomas","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2006.07.030","article-title":"The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes","volume":"194","author":"Simonen","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ajcn\/43.1.92","article-title":"Serum plant sterols and their relation to cholesterol absorption","volume":"43","author":"Tilvis","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diacare.27.1.53","article-title":"Low synthesis and high absorption of cholesterol characterize type 1 diabetes","volume":"27","author":"Miettinen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCGENETICS.109.907873","article-title":"Genetic regulation of serum phytosterol levels and risk of coronary artery disease","volume":"3","author":"Teupser","year":"2010","journal-title":"Circ. Cardiovasc Genet."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2013.01.100","article-title":"High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis","volume":"62","author":"Silbernagel","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib34","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1056\/NEJMoa1405386","article-title":"Inactivating mutations in NPC1L1 and protection from coronary heart disease","volume":"371","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.03.018_bib35","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk. Systemic review and meta-analysis of 40 prospective studies","volume":"120","author":"Di Angelantonio","year":"2009","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T12:42:06Z","timestamp":1655296926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016300934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":35,"alternative-id":["S0021915016300934"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.03.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol metabolism in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}